At Biogen, our focus goes well beyond one specific disease or treatment. We want our science to help solve broader issues affecting society while creating access to further innovation.
Realizing the full potential of biosimilars can deliver sustainable, long-term value for patients, physicians, healthcare systems and society as a whole. With the potential to treat millions more people and save billions in healthcare costs, biosimilars are a core pillar of Biogen’s strategy for growth. Our vision for the future is to be among the global biosimilar leaders.
Biogen biosimilars are benefiting hundreds of thousands of lives today, and we have the potential to treat millions of people in the future.
Healthcare systems can invest savings from biosimilars in expanding access to treatment, improving infrastructure, and providing innovative new medicines.
Biogen seeks to unlock the full potential of our biosimilars business by building our pipeline worldwide. Biosimilars will drive growth at Biogen by generating value for our stakeholders while creating savings that healthcare systems can invest in innovative new treatments.